{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:39:36Z","timestamp":1784356776269,"version":"3.55.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2023MS005"],"award-info":[{"award-number":["TJWJ2023MS005"]}]},{"name":"Tianjin Health Research Project","award":["TJWJ2022ZD003"],"award-info":[{"award-number":["TJWJ2022ZD003"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Breast cancer is the most common malignancy diagnosed in women worldwide. The prevalence and incidence of breast cancer is increasing every year; therefore, early diagnosis along with suitable relapse detection is an important strategy for prognosis improvement. This study aimed to compare different machine algorithms to select the best model for predicting breast cancer recurrence. The prediction model was developed by using eleven different machine learning (ML) algorithms, including logistic regression (LR), random forest (RF), support vector classification (SVC), extreme gradient boosting (XGBoost), gradient boosting decision tree (GBDT), decision tree, multilayer perceptron (MLP), linear discriminant analysis (LDA), adaptive boosting (AdaBoost), Gaussian naive Bayes (GaussianNB), and light gradient boosting machine (LightGBM), to predict breast cancer recurrence. The area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and F1 score were used to evaluate the performance of the prognostic model. Based on performance, the optimal ML was selected, and feature importance was ranked by Shapley Additive Explanation (SHAP) values. Compared to the other 10 algorithms, the results showed that the AdaBoost algorithm had the best prediction performance for successfully predicting breast cancer recurrence and was adopted in the establishment of the prediction model. Moreover, CA125, CEA, Fbg, and tumor diameter were found to be the most important features in our dataset to predict breast cancer recurrence. More importantly, our study is the first to use the SHAP method to improve the interpretability of clinicians to predict the recurrence model of breast cancer based on the AdaBoost algorithm. The AdaBoost algorithm offers a clinical decision support model and successfully identifies the recurrence of breast cancer.<\/jats:p>","DOI":"10.1186\/s12911-023-02377-z","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T16:48:51Z","timestamp":1701276531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Machine learning-based models for the prediction of breast cancer recurrence risk"],"prefix":"10.1186","volume":"23","author":[{"given":"Duo","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer Statistics. 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","DOI":"10.3322\/caac.21654"},{"issue":"7","key":"2377_CR2","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279\u201389.","journal-title":"Lancet Oncol"},{"issue":"13","key":"2377_CR3","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","volume":"24","author":"IL Wapnir","year":"2006","unstructured":"Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr., Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast Tumor recurrence and locoregional recurrences in five National Surgical adjuvant breast and Bowel Project node-positive adjuvant Breast cancer trials. J Clin Oncol. 2006;24(13):2028\u201337.","journal-title":"J Clin Oncol"},{"issue":"19","key":"2377_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-Year risks of Breast-Cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836\u201346.","journal-title":"N Engl J Med"},{"issue":"20","key":"2377_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative Breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"2377_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha EA, Tse GM, Quinn CM. An update on the pathological classification of Breast cancer. Histopathology. 2023;82(1):5\u201316.","journal-title":"Histopathology"},{"issue":"2","key":"2377_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3111\/13696998.2013.864973","volume":"17","author":"T Rautenberg","year":"2014","unstructured":"Rautenberg T, Siebert U, Arnold D, Bennouna J, Kubicka S, Walzer S, et al. Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and\/or epidermal growth factor receptor for the treatment of unresectable metastatic Colorectal cancer. J Med Econ. 2014;17(2):99\u2013110.","journal-title":"J Med Econ"},{"issue":"16","key":"2377_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive Breast cancer. N Engl J Med. 2005;353(16):1659\u201372.","journal-title":"N Engl J Med"},{"issue":"3","key":"2377_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: a review. JAMA. 2019;321(3):288\u2013300.","journal-title":"JAMA"},{"issue":"1","key":"2377_CR10","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr2464","volume":"12","author":"GC Wishart","year":"2010","unstructured":"Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, et al. PREDICT: a new UK prognostic model that predicts survival following Surgery for invasive Breast cancer. Breast Cancer Res. 2010;12(1):R1.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2377_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4048\/jbc.2016.19.3.292","volume":"19","author":"A Pourzand","year":"2016","unstructured":"Pourzand A, Tajaddini A, Pirouzpanah S, Asghari-Jafarabadi M, Samadi N, Ostadrahimi AR, et al. Associations between Dietary Allium vegetables and risk of Breast Cancer: a hospital-based Matched Case-Control Study. J Breast Cancer. 2016;19(3):292\u2013300.","journal-title":"J Breast Cancer"},{"issue":"45","key":"2377_CR12","doi-asserted-by":"publisher","first-page":"27586","DOI":"10.18632\/oncotarget.25496","volume":"9","author":"A Zapater-Moros","year":"2018","unstructured":"Zapater-Moros A, G\u00e1mez-Pozo A, Prado-V\u00e1zquez G, Trilla-Fuertes L, Arevalillo JM, D\u00edaz-Almir\u00f3n M, et al. Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in Breast cancer. Oncotarget. 2018;9(45):27586\u201394.","journal-title":"Oncotarget"},{"issue":"4","key":"2377_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/svn-2017-000101","volume":"2","author":"F Jiang","year":"2017","unstructured":"Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2(4):230\u201343.","journal-title":"Stroke Vasc Neurol"},{"key":"2377_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2019.12.007","volume":"471","author":"S Huang","year":"2020","unstructured":"Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges. Cancer Lett. 2020;471:61\u201371.","journal-title":"Cancer Lett"},{"issue":"13","key":"2377_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jama.2013.393","volume":"309","author":"TB Murdoch","year":"2013","unstructured":"Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA. 2013;309(13):1351\u20132.","journal-title":"JAMA"},{"issue":"6","key":"2377_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/omi.2016.0077","volume":"20","author":"E Kolker","year":"2016","unstructured":"Kolker E, \u00d6zdemir V, Kolker E. How Healthcare can refocus on its super-customers (Patients, n = 1) and customers (doctors and nurses) by leveraging lessons from Amazon, Uber, and Watson. Omics. 2016;20(6):329\u201333.","journal-title":"Omics"},{"key":"2377_CR17","doi-asserted-by":"crossref","unstructured":"Daimiel Naranjo I, Gibbs P, Reiner JS, Lo Gullo R, Sooknanan C, Thakur SB et al. Radiomics and Machine learning with multiparametric breast MRI for Improved Diagnostic accuracy in Breast Cancer diagnosis. Diagnostics (Basel). 2021;11(6).","DOI":"10.3390\/diagnostics11060919"},{"key":"2377_CR18","doi-asserted-by":"publisher","first-page":"749459","DOI":"10.3389\/fimmu.2021.749459","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen Z, Wang M, De Wilde RL, Feng R, Su M, Torres-de la Roche LA, et al. A machine learning model to predict the Triple negative Breast Cancer Immune Subtype. Front Immunol. 2021;12:749459.","journal-title":"Front Immunol"},{"issue":"3","key":"2377_CR19","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00330-021-08271-4","volume":"32","author":"M Ma","year":"2022","unstructured":"Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S, et al. Predicting the molecular subtype of Breast cancer and identifying interpretable imaging features using machine learning algorithms. Eur Radiol. 2022;32(3):1652\u201362.","journal-title":"Eur Radiol"},{"key":"2377_CR20","doi-asserted-by":"crossref","unstructured":"Rasool A, Bunterngchit C, Tiejian L, Islam MR, Qu Q, Jiang Q. Improved Machine Learning-based predictive models for Breast Cancer diagnosis. Int J Environ Res Public Health. 2022;19(6).","DOI":"10.3390\/ijerph19063211"},{"issue":"12","key":"2377_CR21","doi-asserted-by":"publisher","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, Hu Q, Ouyang J, Chen Y, et al. Development and validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in patients with early-stage Breast Cancer. JAMA Netw Open. 2020;3(12):e2028086.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2377_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3892\/ol.2023.14008","volume":"26","author":"J Lee","year":"2023","unstructured":"Lee J, Yoo SK, Kim K, Lee BM, Park VY, Kim JS, et al. Machine learning\u2013based radiomics models for prediction of locoregional recurrence in patients with Breast cancer. Oncol Lett. 2023;26(4):422.","journal-title":"Oncol Lett"},{"key":"2377_CR23","doi-asserted-by":"publisher","first-page":"105569","DOI":"10.1016\/j.compbiomed.2022.105569","volume":"146","author":"X Liu","year":"2022","unstructured":"Liu X, Yuan P, Li R, Zhang D, An J, Ju J, et al. Predicting Breast cancer recurrence and Metastasis risk by integrating color and texture features of histopathological images and machine learning technologies. Comput Biol Med. 2022;146:105569.","journal-title":"Comput Biol Med"},{"key":"2377_CR24","doi-asserted-by":"crossref","unstructured":"Romeo V, Cuocolo R, Sanduzzi L, Carpentiero V, Caruso M, Lama B et al. MRI Radiomics and Machine Learning for the prediction of Oncotype Dx Recurrence score in invasive Breast Cancer. Cancers (Basel). 2023;15(6).","DOI":"10.3390\/cancers15061840"},{"key":"2377_CR25","doi-asserted-by":"publisher","first-page":"103596","DOI":"10.1016\/j.bspc.2022.103596","volume":"75","author":"N Kumar","year":"2022","unstructured":"Kumar N, Sharma M, Singh VP, Madan C, Mehandia S. An empirical study of handcrafted and dense feature extraction techniques for lung and colon Cancer classification from histopathological images. Biomed Signal Process Control. 2022;75:103596.","journal-title":"Biomed Signal Process Control"},{"issue":"12","key":"2377_CR26","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1007\/s12652-021-03256-z","volume":"13","author":"M Sharma","year":"2022","unstructured":"Sharma M, Kumar N. Improved hepatocellular carcinoma fatality prognosis using ensemble learning approach. J Ambient Intell Humaniz Comput. 2022;13(12):5763\u201377.","journal-title":"J Ambient Intell Humaniz Comput"},{"issue":"1","key":"2377_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1148\/radiol.2019182908","volume":"293","author":"A Yala","year":"2019","unstructured":"Yala A, Schuster T, Miles R, Barzilay R, Lehman C. A deep learning model to Triage Screening mammograms: a Simulation Study. Radiology. 2019;293(1):38\u201346.","journal-title":"Radiology"},{"key":"2377_CR28","doi-asserted-by":"crossref","unstructured":"Kumaraswamy E, Kumar S, Sharma M. An invasive ductal carcinomas Breast Cancer Grade classification using an ensemble of convolutional neural networks. Diagnostics [Internet]. 2023; 13(11).","DOI":"10.3390\/diagnostics13111977"},{"key":"2377_CR29","doi-asserted-by":"publisher","first-page":"4253641","DOI":"10.1155\/2019\/4253641","volume":"2019","author":"H Dhahri","year":"2019","unstructured":"Dhahri H, Al Maghayreh E, Mahmood A, Elkilani W, Faisal Nagi M. Automated Breast Cancer diagnosis based on machine learning algorithms. J Healthc Eng. 2019;2019:4253641.","journal-title":"J Healthc Eng"},{"issue":"1","key":"2377_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12885-018-4448-9","volume":"18","author":"J Whitney","year":"2018","unstructured":"Whitney J, Corredor G, Janowczyk A, Ganesan S, Doyle S, Tomaszewski J, et al. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER + Breast cancer. BMC Cancer. 2018;18(1):610.","journal-title":"BMC Cancer"},{"issue":"23","key":"2377_CR31","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","volume":"24","author":"T Bremer","year":"2018","unstructured":"Bremer T, Whitworth PW, Patel R, Savala J, Barry T, Lyle S, et al. A Biological signature for breast ductal carcinoma in situ to predict Radiotherapy Benefit and assess recurrence risk. Clin Cancer Res. 2018;24(23):5895\u2013901.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2377_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1213\/ANE.0000000000003424","volume":"127","author":"TR Vetter","year":"2018","unstructured":"Vetter TR, Schober P. Regression: the Apple does not fall far from the Tree. Anesth Analg. 2018;127(1):277\u201383.","journal-title":"Anesth Analg"},{"issue":"6","key":"2377_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.gpb.2018.08.004","volume":"16","author":"Z Chen","year":"2018","unstructured":"Chen Z, He N, Huang Y, Qin WT, Liu X, Li L. Integration of a deep learning classifier with a Random Forest Approach for Predicting Malonylation sites. Genomics Proteom Bioinf. 2018;16(6):451\u20139.","journal-title":"Genomics Proteom Bioinf"},{"issue":"1","key":"2377_CR34","first-page":"41","volume":"15","author":"S Huang","year":"2018","unstructured":"Huang S, Cai N, Pacheco PP, Narrandes S, Wang Y, Xu W. Applications of support Vector Machine (SVM) Learning in Cancer Genomics. Cancer Genomics Proteomics. 2018;15(1):41\u201351.","journal-title":"Cancer Genomics Proteomics"},{"key":"2377_CR35","doi-asserted-by":"publisher","first-page":"103761","DOI":"10.1016\/j.compbiomed.2020.103761","volume":"121","author":"B Ma","year":"2020","unstructured":"Ma B, Meng F, Yan G, Yan H, Chai B, Song F. Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data. Comput Biol Med. 2020;121:103761.","journal-title":"Comput Biol Med"},{"issue":"1","key":"2377_CR36","doi-asserted-by":"publisher","first-page":"15889","DOI":"10.1038\/s41598-022-20149-z","volume":"12","author":"H Seto","year":"2022","unstructured":"Seto H, Oyama A, Kitora S, Toki H, Yamamoto R, Kotoku J, et al. Gradient boosting decision tree becomes more reliable than logistic regression in predicting probability for Diabetes with big data. Sci Rep. 2022;12(1):15889.","journal-title":"Sci Rep"},{"issue":"10","key":"2377_CR37","doi-asserted-by":"publisher","first-page":"300060521105323","DOI":"10.1177\/03000605211053232","volume":"49","author":"L Wang","year":"2021","unstructured":"Wang L, Zhu L, Jiang J, Wang L, Ni W. Decision tree analysis for evaluating Disease activity in patients with rheumatoid arthritis. J Int Med Res. 2021;49(10):3000605211053232.","journal-title":"J Int Med Res"},{"key":"2377_CR38","doi-asserted-by":"crossref","unstructured":"Yang S, Fu C, Lian X, Dong X, Zhang Z. Understanding human-virus protein-protein interactions using a human protein complex-based analysis Framework. mSystems. 2019;4(2).","DOI":"10.1128\/mSystems.00303-18"},{"issue":"10","key":"2377_CR39","doi-asserted-by":"publisher","first-page":"10200","DOI":"10.1109\/TCYB.2021.3069338","volume":"52","author":"L Xu","year":"2022","unstructured":"Xu L, Raitoharju J, Iosifidis A, Gabbouj M. Saliency-based Multilabel Linear Discriminant Analysis. IEEE Trans Cybern. 2022;52(10):10200\u201313.","journal-title":"IEEE Trans Cybern"},{"issue":"1","key":"2377_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12911-022-02087-y","volume":"22","author":"A Sorayaie Azar","year":"2022","unstructured":"Sorayaie Azar A, Babaei Rikan S, Naemi A, Bagherzadeh Mohasefi J, Pirnejad H, Bagherzadeh Mohasefi M, et al. Application of machine learning techniques for predicting survival in Ovarian cancer. BMC Med Inform Decis Mak. 2022;22(1):345.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2377_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuroimage.2017.09.001","volume":"163","author":"M Ontivero-Ortega","year":"2017","unstructured":"Ontivero-Ortega M, Lage-Castellanos A, Valente G, Goebel R, Valdes-Sosa M. Fast Gaussian Na\u00efve Bayes for searchlight classification analysis. NeuroImage. 2017;163:471\u20139.","journal-title":"NeuroImage"},{"key":"2377_CR42","doi-asserted-by":"crossref","unstructured":"Rufo DD, Debelee TG, Ibenthal A, Negera WG. Diagnosis of Diabetes Mellitus using gradient boosting machine (LightGBM). Diagnostics (Basel). 2021;11(9).","DOI":"10.3390\/diagnostics11091714"},{"issue":"1","key":"2377_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12911-023-02171-x","volume":"23","author":"X Guan","year":"2023","unstructured":"Guan X, Du Y, Ma R, Teng N, Ou S, Zhao H, et al. Construction of the XGBoost model for early Lung cancer prediction based on metabolic indices. BMC Med Inform Decis Mak. 2023;23(1):107.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2377_CR44","doi-asserted-by":"crossref","unstructured":"Ma J, Bo Z, Zhao Z, Yang J, Yang Y, Li H et al. Machine learning to predict the response to Lenvatinib combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2023;15(3).","DOI":"10.3390\/cancers15030625"},{"issue":"1","key":"2377_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1515\/med-2021-0282","volume":"16","author":"PT Yang","year":"2021","unstructured":"Yang PT, Wu WS, Wu CC, Shih YN, Hsieh CH, Hsu JL. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning. Open Med (Wars). 2021;16(1):754\u201368.","journal-title":"Open Med (Wars)"},{"issue":"2","key":"2377_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.18383\/j.tom.2019.00026","volume":"6","author":"CG Bangalore Yogananda","year":"2020","unstructured":"Bangalore Yogananda CG, Shah BR, Vejdani-Jahromi M, Nalawade SS, Murugesan GK, Yu FF, et al. A fully automated deep Learning Network for Brain Tumor Segmentation. Tomography. 2020;6(2):186\u201393.","journal-title":"Tomography"},{"key":"2377_CR47","doi-asserted-by":"publisher","first-page":"816427","DOI":"10.3389\/fonc.2022.816427","volume":"12","author":"Y Mao","year":"2022","unstructured":"Mao Y, Huang Y, Xu L, Liang J, Lin W, Huang H, et al. Surgical methods and social factors are Associated with Long-Term Survival in follicular thyroid carcinoma: construction and validation of a Prognostic Model based on machine learning algorithms. Front Oncol. 2022;12:816427.","journal-title":"Front Oncol"},{"issue":"1","key":"2377_CR48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.21037\/qims-21-39","volume":"12","author":"X Lan","year":"2022","unstructured":"Lan X, Wang X, Qi J, Chen H, Zeng X, Shi J, et al. Application of machine learning with multiparametric dual-energy computed tomography of the breast to differentiate between benign and malignant lesions. Quant Imaging Med Surg. 2022;12(1):810\u201322.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"2377_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4258\/hir.2023.29.3.228","volume":"29","author":"E Miranda","year":"2023","unstructured":"Miranda E, Adiarto S, Bhatti FM, Zakiyyah AY, Aryuni M, Bernando C. Understanding Arteriosclerotic Heart Disease patients using Electronic Health records: a machine learning and Shapley Additive exPlanations Approach. Healthc Inf Res. 2023;29(3):228\u201338.","journal-title":"Healthc Inf Res"},{"key":"2377_CR50","doi-asserted-by":"publisher","first-page":"736491","DOI":"10.3389\/fcvm.2021.736491","volume":"8","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang Y, Li S, Zhang J, Jiang D, Li X, et al. A machine learning-based Prediction Model for Cardiovascular Risk in Women with Preeclampsia. Front Cardiovasc Med. 2021;8:736491.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2377_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-015-0516-0","volume":"17","author":"I Sestak","year":"2015","unstructured":"Sestak I, Cuzick J. Markers for the identification of late Breast cancer recurrence. Breast Cancer Res. 2015;17(1):10.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2377_CR52","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, et al. Basal-like Breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14(5):1368\u201376.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2377_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-011-1564-5","volume":"129","author":"LJ Esserman","year":"2011","unstructured":"Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biologic markers determine both the risk and the timing of recurrence in Breast cancer. Breast Cancer Res Treat. 2011;129(2):607\u201316.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2377_CR54","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for Breast cancer after primary therapy. J Clin Oncol. 1996;14(10):2738\u201346.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2377_CR55","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567\u201375.","journal-title":"N Engl J Med"},{"issue":"9","key":"2377_CR56","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0959-8049(01)00429-4","volume":"38","author":"R Kokko","year":"2002","unstructured":"Kokko R, Holli K, Hakama M. Ca 15 \u2013 3 in the follow-up of localised Breast cancer: a prospective study. Eur J Cancer. 2002;38(9):1189\u201393.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2377_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF00690183","volume":"36","author":"R Molina","year":"1995","unstructured":"Molina R, Zan\u00f3n G, Filella X, Moreno F, Jo J, Daniels M, et al. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in Breast cancer patients. Breast Cancer Res Treat. 1995;36(1):41\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2377_CR58","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"RC Bast Jr","year":"1981","unstructured":"Bast RC Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331\u20137.","journal-title":"J Clin Invest"},{"issue":"5","key":"2377_CR59","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","volume":"15","author":"MJ Duffy","year":"2005","unstructured":"Duffy MJ, Bonfrer JM, Kulpa J, Rustin GJ, Soletormos G, Torre GC, et al. CA125 in Ovarian cancer: European Group on Tumor markers guidelines for clinical use. Int J Gynecol Cancer. 2005;15(5):679\u201391.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2377_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13058-023-01630-7","volume":"25","author":"S Chaudhary","year":"2023","unstructured":"Chaudhary S, Appadurai MI, Maurya SK, Nallasamy P, Marimuthu S, Shah A, et al. MUC16 promotes triple-negative Breast cancer lung Metastasis by modulating RNA-binding protein ELAVL1\/HUR. Breast Cancer Res. 2023;25(1):25.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"2377_CR61","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ejca.2011.07.004","volume":"48","author":"S Reinartz","year":"2012","unstructured":"Reinartz S, Failer S, Schuell T, Wagner U. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and Breast cancer cells. Eur J Cancer. 2012;48(10):1558\u201369.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2377_CR62","first-page":"310","volume":"176","author":"ME van der Burg","year":"1993","unstructured":"van der Burg ME, Lammes FB, Verweij J. The role of CA 125 and conventional examinations in diagnosing Progressive carcinoma of the ovary. Surg Gynecol Obstet. 1993;176(4):310\u20134.","journal-title":"Surg Gynecol Obstet"},{"issue":"3","key":"2377_CR63","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/bjc.1994.333","volume":"70","author":"W J\u00e4ger","year":"1994","unstructured":"J\u00e4ger W, Kissing A, Cilaci S, Melsheimer R, Lang N. Is an increase in CA 125 in Breast cancer patients an indicator of pleural metastases? Br J Cancer. 1994;70(3):493\u20135.","journal-title":"Br J Cancer"},{"issue":"4b","key":"2377_CR64","first-page":"2967","volume":"17","author":"S Kr\u00e4mer","year":"1997","unstructured":"Kr\u00e4mer S, J\u00e4ger W, Lang N. CA 125 is an indicator for pleural metastases in Breast cancer. Anticancer Res. 1997;17(4b):2967\u201370.","journal-title":"Anticancer Res"},{"issue":"1","key":"2377_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/172460089100600101","volume":"6","author":"JL Jensen","year":"1991","unstructured":"Jensen JL, Maclean GD, Suresh MR, Almeida A, Jette D, Lloyd S, et al. Possible utility of serum determinations of CA 125 and CA 27.29 in Breast cancer management. Int J Biol Markers. 1991;6(1):1\u20136.","journal-title":"Int J Biol Markers"},{"key":"2377_CR66","doi-asserted-by":"publisher","first-page":"102434","DOI":"10.1016\/j.ctrv.2022.102434","volume":"109","author":"F De Rose","year":"2022","unstructured":"De Rose F, Meduri B, De Santis MC, Ferro A, Marino L, Colciago RR, et al. Rethinking Breast cancer follow-up based on individual risk and recurrence management. Cancer Treat Rev. 2022;109:102434.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2377_CR67","doi-asserted-by":"publisher","first-page":"e0126276","DOI":"10.1371\/journal.pone.0126276","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Wang X, He H, Liu Z, Hu JF, Li W. Combination of circulating Tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell Lung cancer. PLoS ONE. 2015;10(5):e0126276.","journal-title":"PLoS ONE"},{"issue":"2","key":"2377_CR68","first-page":"1551","volume":"16","author":"W Yang","year":"2018","unstructured":"Yang W, Luo Y, Hu S, Li Y, Liu Q. Value of combined detection of serum carcino-embryonic antigen, carbohydrate antigen 19 \u2013 9 and cyclooxygenase-2 in the diagnosis of Colorectal cancer. Oncol Lett. 2018;16(2):1551\u20136.","journal-title":"Oncol Lett"},{"issue":"3","key":"2377_CR69","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00390469","volume":"108","author":"G Krieger","year":"1984","unstructured":"Krieger G, Wander HE, Kneba M, Prangen M, Bandlow G, Nagel GA. Metastatic Breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis? J Cancer Res Clin Oncol. 1984;108(3):341\u20134.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2377_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cca.2017.04.023","volume":"470","author":"W Wang","year":"2017","unstructured":"Wang W, Xu X, Tian B, Wang Y, Du L, Sun T, et al. The diagnostic value of serum Tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic Breast cancer. Clin Chim Acta. 2017;470:51\u20135.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2377_CR71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.neo.7900263","volume":"4","author":"GJ Caine","year":"2002","unstructured":"Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465\u201373.","journal-title":"Neoplasia"},{"issue":"6","key":"2377_CR72","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3324\/haematol.2019.228981","volume":"105","author":"C Giaccherini","year":"2020","unstructured":"Giaccherini C, Marchetti M, Masci G, Verzeroli C, Russo L, Celio L, et al. Thrombotic biomarkers for risk prediction of malignant Disease recurrence in patients with early stage Breast cancer. Haematologica. 2020;105(6):1704\u201311.","journal-title":"Haematologica"},{"issue":"11","key":"2377_CR73","first-page":"673","volume":"1","author":"A Falanga","year":"2003","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D. Clotting mechanisms and cancer: implications in thrombus formation and Tumor progression. Clin Adv Hematol Oncol. 2003;1(11):673\u20138.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"6","key":"2377_CR74","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.breast.2015.09.007","volume":"24","author":"J Wen","year":"2015","unstructured":"Wen J, Yang Y, Ye F, Huang X, Li S, Wang Q, et al. The preoperative plasma fibrinogen level is an Independent prognostic factor for overall survival of Breast cancer patients who underwent surgical treatment. Breast. 2015;24(6):745\u201350.","journal-title":"Breast"},{"issue":"5","key":"2377_CR75","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.breast.2015.08.003","volume":"24","author":"S Krenn-Pilko","year":"2015","unstructured":"Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, et al. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in Breast cancer patients. Breast. 2015;24(5):667\u201372.","journal-title":"Breast"},{"issue":"3","key":"2377_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.bjc.6600069","volume":"86","author":"LY Dirix","year":"2002","unstructured":"Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic Breast cancer. Br J Cancer. 2002;86(3):389\u201395.","journal-title":"Br J Cancer"},{"key":"2377_CR77","doi-asserted-by":"publisher","first-page":"4295029","DOI":"10.1155\/2016\/4295029","volume":"2016","author":"K Teke\u015fin","year":"2016","unstructured":"Teke\u015fin K, Bayrak S, Esato\u011flu V, \u00d6zdemir E, \u00d6zel L, Melih Kara V. D-Dimer and Carcinoembryonic Antigen levels: useful indicators for Predicting the Tumor Stage and Postoperative Survival. Gastroenterol Res Pract. 2016;2016:4295029.","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"2377_CR78","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrclinonc.2010.39","volume":"7","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Reis-Filho JS, Narod SA. Tumor size and survival in Breast cancer\u2014a reappraisal. Nat Reviews Clin Oncol. 2010;7(6):348\u201353.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"Suppl 2","key":"2377_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B, Galv\u00e1n P, Fern\u00e1ndez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of Breast cancer. Breast. 2015;24(Suppl 2):26\u201335.","journal-title":"Breast"},{"issue":"13","key":"2377_CR80","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1158\/0008-5472.CAN-16-2574","volume":"77","author":"J Holm","year":"2017","unstructured":"Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, et al. Assessment of Breast Cancer risk factors reveals subtype heterogeneity. Cancer Res. 2017;77(13):3708\u201317.","journal-title":"Cancer Res"},{"issue":"10","key":"2377_CR81","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","volume":"28","author":"KD Voduc","year":"2010","unstructured":"Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684\u201391.","journal-title":"J Clin Oncol"},{"issue":"16","key":"2377_CR82","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","volume":"96","author":"CM Perou","year":"1999","unstructured":"Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A. 1999;96(16):9212\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2377_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","volume":"170","author":"V Sopik","year":"2018","unstructured":"Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of Breast cancer. Breast Cancer Res Treat. 2018;170(3):647\u201356.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2377_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Reviews Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Reviews Clin Oncol"},{"key":"2377_CR85","doi-asserted-by":"publisher","first-page":"102276","DOI":"10.1016\/j.artmed.2022.102276","volume":"127","author":"AB Nassif","year":"2022","unstructured":"Nassif AB, Talib MA, Nasir Q, Afadar Y, Elgendy O. Breast cancer detection using artificial intelligence techniques: a systematic literature review. Artif Intell Med. 2022;127:102276.","journal-title":"Artif Intell Med"},{"issue":"12","key":"2377_CR86","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.xcrm.2022.100851","volume":"3","author":"CA La Porta","year":"2022","unstructured":"La Porta CA, Zapperi S. Artificial intelligence in Breast cancer diagnostics. Cell Rep Med. 2022;3(12):100851.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2377_CR87","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/his.14820","volume":"82","author":"RC Chan","year":"2023","unstructured":"Chan RC, To CKC, Cheng KCT, Yoshikazu T, Yan LLA, Tse GM. Artificial intelligence in Breast cancer histopathology. Histopathology. 2023;82(1):198\u2013210.","journal-title":"Histopathology"},{"issue":"5","key":"2377_CR88","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.118.024293","volume":"50","author":"J Heo","year":"2019","unstructured":"Heo J, Yoon JG, Park H, Kim YD, Nam HS, Heo JH. Machine learning-based model for prediction of outcomes in Acute Stroke. Stroke. 2019;50(5):1263\u20135.","journal-title":"Stroke"},{"issue":"12","key":"2377_CR89","doi-asserted-by":"publisher","first-page":"e0226765","DOI":"10.1371\/journal.pone.0226765","volume":"14","author":"GF Stark","year":"2019","unstructured":"Stark GF, Hart GR, Nartowt BJ, Deng J. Predicting Breast cancer risk using personal health data and machine learning models. PLoS ONE. 2019;14(12):e0226765.","journal-title":"PLoS ONE"},{"issue":"1","key":"2377_CR90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13054-021-03724-0","volume":"25","author":"J Dong","year":"2021","unstructured":"Dong J, Feng T, Thapa-Chhetry B, Cho BG, Shum T, Inwald DP, et al. Machine learning model for early prediction of acute kidney injury (AKI) in pediatric critical care. Crit Care. 2021;25(1):288.","journal-title":"Crit Care"},{"key":"2377_CR91","doi-asserted-by":"publisher","first-page":"103580","DOI":"10.1016\/j.compbiomed.2019.103580","volume":"116","author":"RJ Kate","year":"2020","unstructured":"Kate RJ, Pearce N, Mazumdar D, Nilakantan V. A continual prediction model for inpatient acute kidney injury. Comput Biol Med. 2020;116:103580.","journal-title":"Comput Biol Med"},{"key":"2377_CR92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.msksp.2018.11.012","volume":"39","author":"C Tack","year":"2019","unstructured":"Tack C. Artificial intelligence and machine learning | applications in musculoskeletal physiotherapy. Musculoskelet Sci Pract. 2019;39:164\u20139.","journal-title":"Musculoskelet Sci Pract"},{"key":"2377_CR93","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.ctarc.2022.100602","volume":"32","author":"SR Gupta","year":"2022","unstructured":"Gupta SR. Prediction time of Breast cancer Tumor recurrence using machine learning. Cancer Treat Res Commun. 2022;32:100602.","journal-title":"Cancer Treat Res Commun"},{"issue":"2","key":"2377_CR94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/RLI.0000000000000518","volume":"54","author":"A Tahmassebi","year":"2019","unstructured":"Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, et al. Impact of machine learning with Multiparametric magnetic resonance imaging of the breast for early prediction of response to Neoadjuvant Chemotherapy and survival outcomes in Breast Cancer patients. Invest Radiol. 2019;54(2):110\u20137.","journal-title":"Invest Radiol"},{"issue":"6","key":"2377_CR95","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1874-1029(13)60052-X","volume":"39","author":"Y Cao","year":"2013","unstructured":"Cao Y, Miao Q-G, Liu J-C, Gao L. Advance and prospects of AdaBoost Algorithm. Acta Automatica Sinica. 2013;39(6):745\u201358.","journal-title":"Acta Automatica Sinica"},{"issue":"11","key":"2377_CR96","doi-asserted-by":"publisher","first-page":"e0142827","DOI":"10.1371\/journal.pone.0142827","volume":"10","author":"G Stiglic","year":"2015","unstructured":"Stiglic G, Pajnkihar M. Evaluation of major online Diabetes risk calculators and computerized predictive models. PLoS ONE. 2015;10(11):e0142827.","journal-title":"PLoS ONE"},{"key":"2377_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neucom.2017.02.077","volume":"248","author":"MM Baig","year":"2017","unstructured":"Baig MM, Awais MM, El-Alfy E-SM. AdaBoost-based artificial neural network learning. Neurocomputing. 2017;248:120\u20136.","journal-title":"Neurocomputing"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02377-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-023-02377-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02377-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:29:00Z","timestamp":1701318540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-023-02377-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1186\/s12911-023-02377-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki and has been approved by the Ethical Committee of Tianjin Medical University Cancer Institute and Hospital (No. bc2021230 and No. bc2023158), and consent was obtained for the raw data collection in the patients\u2019 electronic records. The need for informed consent was waived by the Ethics Committee\/Institutional Review Board of Tianjin Medical University Cancer Institute and Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}